These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term iTBS Improves Neural Functional Recovery by Reducing the Inflammatory Response and Inhibiting Neuronal Apoptosis Via miR-34c-5p/p53/Bax Signaling Pathway in Cerebral Ischemic Rats. Hu S, Wang X, Yang X, Ouyang S, Pan X, Fu Y, Wu S. Neuroscience; 2023 Sep 01; 527():37-51. PubMed ID: 37468029 [Abstract] [Full Text] [Related]
5. High-frequency repetitive transcranial magnetic stimulation (rTMS) protects against ischemic stroke by inhibiting M1 microglia polarization through let-7b-5p/HMGA2/NF-κB signaling pathway. Hong Y, Lyu J, Zhu L, Wang X, Peng M, Chen X, Deng Q, Gao J, Yuan Z, Wang D, Xu G, Xu M. BMC Neurosci; 2022 Aug 04; 23(1):49. PubMed ID: 35927640 [Abstract] [Full Text] [Related]
6. Downregulation of Nogo-B ameliorates cerebral ischemia/reperfusion injury in mice through regulating microglia polarization via TLR4/NF-kappaB pathway. Gong P, Jia HY, Li R, Ma Z, Si M, Qian C, Zhu FQ, Sheng-Yong L. Neurochem Int; 2023 Jul 04; 167():105553. PubMed ID: 37230196 [Abstract] [Full Text] [Related]
7. Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia/Macrophage Pyroptosis through NF-κB Suppression and NLRP3 Inflammasome Inhibition. Ran Y, Su W, Gao F, Ding Z, Yang S, Ye L, Chen X, Tian G, Xi J, Liu Z. Oxid Med Cell Longev; 2021 Jul 04; 2021():1552127. PubMed ID: 34630845 [Abstract] [Full Text] [Related]
8. Qingda granule alleviates cerebral ischemia/reperfusion injury by inhibiting TLR4/NF-κB/NLRP3 signaling in microglia. Cai Q, Zhao C, Xu Y, Lin H, Jia B, Huang B, Lin S, Chen D, Jia P, Wang M, Lin W, Zhang L, Chu J, Peng J. J Ethnopharmacol; 2024 Apr 24; 324():117712. PubMed ID: 38184025 [Abstract] [Full Text] [Related]
9. Salvianolic Acids for Injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro. Ma DC, Zhang NN, Zhang YN, Chen HS. J Ethnopharmacol; 2021 Apr 24; 270():113776. PubMed ID: 33421597 [Abstract] [Full Text] [Related]
10. Bone marrow mesenchymal stem cell-derived exosomes attenuate cerebral ischemia-reperfusion injury-induced neuroinflammation and pyroptosis by modulating microglia M1/M2 phenotypes. Liu X, Zhang M, Liu H, Zhu R, He H, Zhou Y, Zhang Y, Li C, Liang D, Zeng Q, Huang G. Exp Neurol; 2021 Jul 24; 341():113700. PubMed ID: 33741350 [Abstract] [Full Text] [Related]
11. Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation. Li X, Yao M, Li L, Ma H, Sun Y, Lu X, Jing W, Nie S. Phytomedicine; 2024 Jul 24; 129():155578. PubMed ID: 38621328 [Abstract] [Full Text] [Related]
15. STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke. Li W, Shen N, Kong L, Huang H, Wang X, Zhang Y, Wang G, Xu P, Hu W. Stroke Vasc Neurol; 2024 Apr 30; 9(2):153-164. PubMed ID: 37402504 [Abstract] [Full Text] [Related]
18. CX3CL1 inhibits NLRP3 inflammasome-induced microglial pyroptosis and improves neuronal function in mice with experimentally-induced ischemic stroke. Ge Y, Wang L, Wang C, Chen J, Dai M, Yao S, Lin Y. Life Sci; 2022 Jul 01; 300():120564. PubMed ID: 35461837 [Abstract] [Full Text] [Related]
19. Argon mitigates post-stroke neuroinflammation by regulating M1/M2 polarization and inhibiting NF-κB/NLRP3 inflammasome signaling. Xue K, Qi M, She T, Jiang Z, Zhang Y, Wang X, Wang G, Xu L, Peng B, Liu J, Song X, Yuan Y, Li X. J Mol Cell Biol; 2023 Apr 20; 14(12):. PubMed ID: 36574951 [Abstract] [Full Text] [Related]
20. Baicalein ameliorates ischemic brain damage through suppressing proinflammatory microglia polarization via inhibiting the TLR4/NF-κB and STAT1 pathway. Ran Y, Qie S, Gao F, Ding Z, Yang S, Tian G, Liu Z, Xi J. Brain Res; 2021 Nov 01; 1770():147626. PubMed ID: 34418356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]